Roche

News of Roche, the Swiss biotech company with worldwide business in diagnostics and pharmaceuticals. The global leader in cancer treatments and a Top 5 pharmaceutical company, Roche controls the American biotech Genentech and the Japanese tech company Chugai Pharmaecueticals.

Latest

Pharma Andrew Joseph

STAT Plus: Roche seeks to project confidence on its obesity drugs — and sees room to make its mark

Pharma Jonathan Wosen

STAT Plus: FDA approves Roche’s injectable version of blockbuster multiple sclerosis drug

Exclusive Elizabeth Cohen

STAT Plus: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers

Biotech Jonathan Saltzman — Boston Globe

STAT Plus: Roche subsidiary Foundation Medicine opens new headquarters in Boston

The Readout LOUD Damian Garde, Allison DeAngelis, and Adam Feuerstein

Vivek’s star turn, leaky drug data, & biotech as family business

Biotech Andrew Joseph and Damian Garde

STAT Plus: In the case of a devastating disease, the FDA weighs an experimental drug’s muddled data and a desperate need

Pharmalot Ed Silverman

STAT Plus: EPA fines Roche’s Genentech unit for hazardous waste violations

Biotech Matthew Herper

STAT Plus: Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

All Coverage

Pharmalot Ed Silverman

STAT Plus: Turkish court hands Novartis and Roche a rare win over their efforts to promote an eye treatment

Biotech Jason Mast

STAT Plus: Roche pharmaceuticals CEO Bill Anderson to step down after four-year tenure

Biotech Damian Garde and Jonathan Wosen

STAT Plus: Roche’s failed Alzheimer’s studies lend weight to an emerging idea about potential treatments

Biotech Adam Feuerstein and Damian Garde